Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 ICD-10-CM code M32.13

Lung involvement in systemic lupus erythematosus; pleural effusion due to systemic lupus erythematosus.

Refer to the latest ICD-10-CM coding guidelines and official documentation for accurate coding practices.Additional codes may be needed to capture the full clinical picture, including the type of lung involvement, associated conditions, and treatments provided.

Medical necessity for the diagnosis and treatment of lung involvement in SLE is established through clinical findings and diagnostic test results demonstrating the presence and severity of pulmonary complications directly attributable to SLE.The treatment plan should be tailored to the individual patient's needs and the specific type and severity of lung involvement.

Diagnosis and management of lung involvement in SLE require a multidisciplinary approach.Pulmonologists, rheumatologists, and other specialists may be involved, depending on the severity and complexity of the case. The clinical responsibility includes obtaining a thorough history, performing physical examinations, ordering and interpreting diagnostic tests (chest X-rays, CT scans, pulmonary function tests, blood tests), and determining appropriate treatment strategies.

IMPORTANT:Consider additional codes to specify the type of lung involvement (e.g., pleural effusion, pneumonitis) and any associated conditions.

In simple words: This code describes lung problems caused by lupus, a disease affecting the body's connective tissues.Lung issues from lupus can include fluid around the lungs, lung inflammation, or bleeding in the lungs, and can range from mild to severe.

M32.13, Lung involvement in systemic lupus erythematosus, signifies pulmonary complications arising from systemic lupus erythematosus (SLE).This can manifest as various conditions, including pleural effusion (fluid buildup around the lungs), pleuritis (inflammation of the pleural lining), pneumonitis (lung inflammation), alveolar hemorrhage (bleeding into the alveoli), and interstitial lung disease (ILD). The severity ranges from asymptomatic to life-threatening.

Example 1: A 35-year-old female with a history of SLE presents with shortness of breath and chest pain.Imaging reveals a pleural effusion.The patient is treated with anti-inflammatory medications and supportive care., A 40-year-old male with SLE experiences acute onset dyspnea and hemoptysis.Diagnosis of alveolar hemorrhage is made, requiring aggressive treatment with corticosteroids and immunosuppressants., A 28-year-old female with SLE is diagnosed with interstitial lung disease.Management includes pulmonary rehabilitation and medications to slow disease progression.

Detailed patient history, including symptoms (e.g., cough, dyspnea, chest pain), SLE history, and medication use. Results of physical exam, chest X-ray, CT scan, pulmonary function tests, and blood work (including autoantibody testing). Treatment plan, response to treatment, and any complications.

** Always consult the latest ICD-10-CM coding manual and other relevant resources to ensure accurate coding and billing practices.Consider using additional codes to clarify the type and severity of lung involvement.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.